Orris

Management of acute ge

Reading File
Finding Sources
Searching PubMed

"acute gastroenteritis" AND management

Finding Sources
Finding Sources
Reading File
Finding Sources
Reading File
Finding Sources
Reading File
Finding Sources
Reading File
Finding Sources
Reading File
Finding Sources
Reading File
Finding Sources
Searching Images

acute gastroenteritis management algorithm oral rehydration dehydration

This clinical photograph displays a young child exhibiting classic signs of severe dehydration, likely secondary to acute watery diarrhea. The primary visual finding is the presence of deeply sunken eyes (enophthalmos), a critical physical marker of significant fluid volume deficit. The child demonstrates a depressed level of consciousness, appearing obtunded or lethargic with eyes closed and a lack of responsiveness to the surrounding environment. The facial features appear pinched, and there is a suggestion of reduced tissue turgor. This image serves as an educational tool for identifying the clinical 'danger signs' of dehydration in pediatric patients, emphasizing the need for urgent fluid resuscitation, such as intravenous therapy or intensive oral rehydration salts (ORS) protocols. The context suggests a global health setting where monitoring and managing electrolyte balance is vital for survival in cases of severe diarrheal illness.

This clinical photograph displays a young child exhibiting classic signs of severe dehydration, likely secondary to acute watery diarrhea. The primary visual finding is the presence of deeply sunken eyes (enophthalmos), a critical physical marker of significant fluid volume deficit. The child demonstrates a depressed level of consciousness, appearing obtunded or lethargic with eyes closed and a lack of responsiveness to the surrounding environment. The facial features appear pinched, and there is a suggestion of reduced tissue turgor. This image serves as an educational tool for identifying the clinical 'danger signs' of dehydration in pediatric patients, emphasizing the need for urgent fluid resuscitation, such as intravenous therapy or intensive oral rehydration salts (ORS) protocols. The context suggests a global health setting where monitoring and managing electrolyte balance is vital for survival in cases of severe diarrheal illness.

This medical infographic presents three clinical algorithms (A, B, and C) for managing massive bleeding in acute settings. Algorithm A details a ROTEM-guided approach for uncoagulated patients, using viscoelastic parameters (EXTEM, FIBTEM, APTEM) to differentiate and treat hyperfibrinolysis (tranexamic acid), hypofibrinogenemia (fibrinogen concentrate), thrombin deficiency (prothrombin complex), and thrombocytopenia. Algorithm B outlines management for uncoagulated patients when ROTEM is unavailable, focusing on monitoring for the 'lethal triad' (acidosis, hypothermia, coagulopathy), lab values like hemoglobin and base excess, and the administration of blood products or PCC. Algorithm C addresses oral anticoagulant overdose, branching by agent type: Vitamin K Antagonists (VKA) or Direct Oral Anticoagulants (DOACs). It provides decision nodes based on INR levels and hemorrhage severity, recommending reversal agents such as Vitamin K, prothrombin complex (PCC), or Idarucizumab for dabigatran. The diagrams use standardized medical terminology and dosage guidelines suitable for emergency medicine, hematology, and trauma surgery education.

This medical infographic presents three clinical algorithms (A, B, and C) for managing massive bleeding in acute settings. Algorithm A details a ROTEM-guided approach for uncoagulated patients, using viscoelastic parameters (EXTEM, FIBTEM, APTEM) to differentiate and treat hyperfibrinolysis (tranexamic acid), hypofibrinogenemia (fibrinogen concentrate), thrombin deficiency (prothrombin complex), and thrombocytopenia. Algorithm B outlines management for uncoagulated patients when ROTEM is unavailable, focusing on monitoring for the 'lethal triad' (acidosis, hypothermia, coagulopathy), lab values like hemoglobin and base excess, and the administration of blood products or PCC. Algorithm C addresses oral anticoagulant overdose, branching by agent type: Vitamin K Antagonists (VKA) or Direct Oral Anticoagulants (DOACs). It provides decision nodes based on INR levels and hemorrhage severity, recommending reversal agents such as Vitamin K, prothrombin complex (PCC), or Idarucizumab for dabigatran. The diagrams use standardized medical terminology and dosage guidelines suitable for emergency medicine, hematology, and trauma surgery education.

This medical illustration depicts the effects of acute plasma osmolality shifts on the brain in a coronal cross-section. The diagram is divided into three panels: a central 'Normal Brain' (normal osmolarity), a 'Hypo-osmotic State' (left), and a 'Hyper-osmotic State' (right). The hypo-osmotic panel illustrates cerebral swelling typically caused by SIADH, rapid rehydration, or dialysis disequilibrium. Key findings include brainstem downward displacement (indicated by blue arrows) and contusions (red X/XX) from contact with the meninges and foramen magnum. The hyper-osmotic panel illustrates water loss and brain shrinkage due to dehydration, renal insufficiency, or rapid mannitol therapy. Significant markers include the brain 'sinking' (magenta arrows), stretching of cortical vessels (indicated by 'O'), and pontine white matter demyelination ('XXX'). A horizontal axis at the bottom highlights the risks of 'Too rapid dehydration' and 'Too rapid rehydration' as iatrogenic drivers of these transitions. The illustration serves as a clinical guide for understanding the Monro-Kellie doctrine and the mechanical consequences of osmotic brain injury, specifically focusing on herniation and vascular damage.

This medical illustration depicts the effects of acute plasma osmolality shifts on the brain in a coronal cross-section. The diagram is divided into three panels: a central 'Normal Brain' (normal osmolarity), a 'Hypo-osmotic State' (left), and a 'Hyper-osmotic State' (right). The hypo-osmotic panel illustrates cerebral swelling typically caused by SIADH, rapid rehydration, or dialysis disequilibrium. Key findings include brainstem downward displacement (indicated by blue arrows) and contusions (red X/XX) from contact with the meninges and foramen magnum. The hyper-osmotic panel illustrates water loss and brain shrinkage due to dehydration, renal insufficiency, or rapid mannitol therapy. Significant markers include the brain 'sinking' (magenta arrows), stretching of cortical vessels (indicated by 'O'), and pontine white matter demyelination ('XXX'). A horizontal axis at the bottom highlights the risks of 'Too rapid dehydration' and 'Too rapid rehydration' as iatrogenic drivers of these transitions. The illustration serves as a clinical guide for understanding the Monro-Kellie doctrine and the mechanical consequences of osmotic brain injury, specifically focusing on herniation and vascular damage.

Here is a comprehensive summary of the management of acute gastroenteritis (AGE), synthesized from Tintinalli's Emergency Medicine and Rosen's Emergency Medicine, supplemented by recent evidence.

Management of Acute Gastroenteritis (AGE)

Overview

Acute gastroenteritis is defined by infectious inflammation of the GI tract causing diarrhea (with or without vomiting), abdominal cramps, and sometimes fever. The cornerstone of management is preventing and correcting dehydration - not eliminating the pathogen. The majority of cases are viral (rotavirus, norovirus) and self-limiting. - Tintinalli's Emergency Medicine, p. 885

Step 1 - Assess Dehydration Severity

Use the Clinical Dehydration Score (CDS) to guide therapy:
ScoreAppearanceEyesOral MucosaTearsInterpretation
0NormalNormalMoistNormalNo dehydration
1Thirsty/restlessMildly sunkenStickyDecreasedSome dehydration
2Drowsy/limp/cold/diaphoreticVery sunkenDryNoneSevere dehydration
Score >0 = some dehydration; score >5 = moderate-severe dehydration.
Signs prompting IV rehydration: severe dehydration, hemodynamic compromise, altered mental status, inability to take oral fluids.

Step 2 - Oral Rehydration Therapy (ORT) - First-Line

ORT exploits the Na⁺-glucose co-transport mechanism at the brush border of intestinal epithelial cells - this coupled transport remains intact even in severe diarrheal disease and drives passive water absorption optimally at a 1:1 sodium-to-glucose ratio.

ORS Formulations

SolutionNa⁺ (mmol/L)Glucose (mmol/L)Osmolarity
WHO reduced-osmolarity (2002)7575245 mOsm/L
Pedialyte45139~250 mOsm/L
Sports drinks / juicesVery lowVery highNOT suitable
  • The WHO reduced-osmolarity ORS reduces stool output, vomiting, and need for IV therapy compared to the older high-osmolarity formula.
  • Sports drinks, juice, and tea are not appropriate rehydration fluids - they are low in sodium and may worsen osmotic losses.
  • In mild dehydration in high-income settings, dilute apple juice followed by preferred fluids is an acceptable, evidence-supported alternative.

ORT Technique

  • Give small, frequent volumes (5 mL every 1-2 minutes via syringe or spoon).
  • Replace ongoing losses: approximately 10 mL/kg for each loose stool, 2 mL/kg for each episode of vomiting.
  • Educate caregivers before discharge and provide written instructions. - Tintinalli's Emergency Medicine, p. 887-888

Step 3 - IV Rehydration (Reserved Cases)

IV rehydration is appropriate for:
  • Severe dehydration or hemodynamic instability
  • Inability to tolerate oral fluids (persistent vomiting, altered consciousness)
  • Failed ORT (approximately 1 in 25 children on ORT will require IV escalation)
A Cochrane review found no difference in failure to rehydrate or weight gain between ORT and IV therapy, but ORT is associated with a shorter hospital stay. - Tintinalli's Emergency Medicine, p. 888

Step 4 - Antiemetics

Vomiting is not a contraindication to ORT and does not usually prevent successful oral rehydration. When ongoing vomiting impedes ORT:
  • Ondansetron (5-HT3 antagonist): First-line antiemetic, 0.15 mg/kg PO (single dose). A 2016 meta-analysis confirmed robust evidence for use in children. A single oral dose is sufficient - IV and multiple doses add side effects without additional benefit.
  • Avoid dopamine receptor antagonists (promethazine, prochlorperazine, metoclopramide, droperidol) in children - risk of extrapyramidal reactions and respiratory depression. Promethazine is contraindicated in children <2 years (FDA black-box warning for fatal respiratory depression).
  • In adults, antiemetics (ondansetron, metoclopramide) are used freely to facilitate oral intake and comfort.

Step 5 - Diet and Feeding

  • Resume an age-appropriate, nutritionally complete diet as soon as the initial fluid deficit is replaced - do not withhold feeds for >4 hours in a dehydrated child, or at all in a non-dehydrated child.
  • Early refeeding is supported by all major guidelines and is associated with increased weight gain and faster mucosal recovery.
  • Full-strength formula or regular diet can be restarted immediately after rehydration - dilution is not necessary.
  • Most children tolerate lactose-containing milk/formula; lactose-free products may slightly reduce diarrhea duration in hospitalized patients.
  • The BRAT diet (banana, rice, applesauce, toast) is no longer recommended - it is unnecessarily restrictive and calorically insufficient.
  • Low-fat diets are discouraged (fats are important caloric sources during recovery). - Tintinalli's Emergency Medicine, p. 889

Step 6 - Adjunct Agents

Antidiarrheal Medications

  • Loperamide: Absolutely contraindicated in children <2 years old and with bloody stools, suspected bacterial gastroenteritis (Salmonella, Shigella, Campylobacter) - risk of lethargy, paralytic ileus, and potentially HUS in E. coli O157:H7. May be used cautiously in adults with mild-moderate watery diarrhea.
  • Bismuth subsalicylate: Modest antisecretory effect; avoid exceeding recommended doses in children <12 years (salicylate toxicity risk).
  • Racecadotril (enkephalinase inhibitor): Available in Europe/SE Asia; reduces stool frequency but does not reduce hospitalization rates.
  • Smectite: Used in some European countries; limited evidence.

Probiotics

  • Not recommended in current guidelines for acute pediatric gastroenteritis in ED settings. Two large multicenter RCTs (>1500 combined participants) showed no benefit for Lactobacillus rhamnosus GG. Product labeling is also often inaccurate. Only a minority of published AGE management guidelines endorse probiotics.
  • However, a 2025 meta-analysis (PMID: 40739406) suggests some benefit in reducing duration and severity in children - this may prompt future guideline updates.

Zinc

  • Beneficial primarily in malnourished children >6 months in low-income settings (reduces diarrhea duration by ~27 hours). Not routinely recommended in well-nourished children in high-income countries. Reduces morbidity and mortality in resource-poor settings. - Tintinalli's Emergency Medicine, p. 890

Step 7 - Antibiotics

Do not give empiric antibiotics routinely. The vast majority of pediatric AGE is viral. Antibiotics are indicated only in select circumstances:
PathogenRecommendation
ShigellaTreat all cases - azithromycin (first-line); ceftriaxone for parenteral therapy. Ampicillin/TMP-SMX only if susceptible.
Salmonella (non-typhoidal)Do NOT treat routine cases - a Cochrane review (12 trials, 767 patients) showed no benefit and more adverse events with antibiotics. Treat only high-risk patients: <3 months, immunocompromised, sickle cell disease, IBD.
CampylobacterTreat if started within 3 days of onset; azithromycin preferred (high fluoroquinolone resistance).
E. coli O157:H7 / STECContraindicated - antibiotics significantly increase the risk of hemolytic-uremic syndrome (HUS).
Cholera (V. cholerae)Doxycycline, azithromycin, or TMP-SMX.
YersiniaTreat only if severe disease, bacteremia, or extraintestinal infection - TMP-SMX, aminoglycosides, fluoroquinolones, doxycycline.
C. difficileStop offending antibiotic if possible; treat with oral vancomycin or fidaxomicin.
Parenteral antibiotics are appropriate for: toxic/septic appearance, underlying immune deficiency, febrile infants <3 months. - Tintinalli's Emergency Medicine, p. 890-891

Step 8 - Disposition

Discharge is appropriate for well-appearing patients with:
  • Minimal or no dehydration
  • Ability to tolerate ORT at home
  • Caregiver able to administer ORT and recognize signs of deterioration
Admit or observe patients with:
  • Moderate-severe dehydration
  • Intractable or bilious vomiting
  • Suspected surgical condition (peritoneal signs, bilious emesis)
  • Significant lab or neurologic abnormalities (lethargy, seizures)
  • Young infants (low threshold for admission)
  • Inadequate social support for home ORT
Return precautions: inability to tolerate ORT, persistent/bilious emesis, increasing signs of dehydration, worsening symptoms.

Summary Table: Treatment by Dehydration Status

SeverityManagement
None / MinimalEarly refeeding, replace ongoing losses with ORS, discharge with education
Mild-ModerateORT (50-100 mL/kg over 2-4 hours), reassess, resume diet after rehydration
SevereIV rehydration (20 mL/kg boluses), correct electrolyte abnormalities, admit
Recent evidence note: A 2025 meta-analysis (PMID: 40739406) suggests probiotics may reduce duration and severity in pediatric AGE - this may update current recommendations that advise against routine use.
This is a shared conversation. Sign in to Orris to start your own chat.